Tevogen Bio Holdings Inc. - Common Stock — 분기별 재무제표 (NASDAQ:TVGN) | MetaTrader

전체 차트 열기 Full chart

뉴스

Tevogen Bio Explores Buyout To Boost Generics Platform - Tevogen Bio Holdings (NASDAQ:TVGN)

D. Boral Capital, Tevogen Bio 목표 주가 2달러로 하향 조정

D. Boral Capital lowers Tevogen Bio stock price target to $2 on dilution risk

Tevogen, 특별 현금 배당 가능성 검토

Tevogen board to evaluate potential special cash dividend

Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Anglogold Ashanti (NYSE:AU), HeartBeam (NASDAQ:BEAT)

테보젠 바이오, 나스닥 최저 입찰가 미달 통지 받아

Tevogen Bio Holdings receives Nasdaq notice for minimum bid price deficiency

Tevogen announces $9-11 billion valuation for COVID-19 T cell therapy

Tevogen shares EBV treatment forecast with $3.5 billion revenue potential

Tevogen highlights need for SARS-CoV-2 treatments for immunocompromised

Tevogen reports 60% rise in institutional ownership in Q1 2025